Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back and good morning! It’s the start of the week and that means it’s time for investors to get back into the game. We’re here to help with that as we take a look at the biggest pre-market stock...
One of the best performing stocks in April was Brooklyn ImmunoTherapuetics (BTX), which only began trading in late March.Shares have risen more than 1200% in the last month.Brooklyn was formed through a reverse merger with the trivia apps company NTN Buzztime.In April, Brooklyn's biggest anno...
3 Penny Stocks To Buy According To Wall Street Analysts It’s May, and penny stocks are back on the menu to kick things off. But, if you’re new to trading, you may have a few questions before deciding what to buy. First, what are penny stocks ? How do you find them and ...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks fell broadly Friday, as investors took profits following a flurry of earnings reports, including a blowout quarter from Amazon, and an...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Brooklyn ImmunoTherapeutics (NYSEMKT: BTX ) and BTX stock are seeing absolutely explosive gains. The stock is up approximately 50% at the time of writing on very heavy volume. Curren...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +58%.Regional Health Properties (RHE) +49%.Motus GI Holdings (MOTS) +31%.Bel Fuse (BELFB) +29%.Image Sensing Systems (ISNS) +23%.Farmmi (FAMI) +20%.CryoLife (CRY) +18%.Naked Brand (NAKD) +17%.Laureate Education (LAUR) +14%.Insignia Sys...
Brooklyn ImmoTherapeutics LLC (NYSE: BTX) reported that is has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics Limited. This will include an extensive patented process to develop gen...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +38%, Motus GI MOTS +32%, CryoLife (CRY) +16%, Mesoblast MESO +14%, Arcutis Biotherapeutics (ARQT) +10%.Losers: Ardelyx (ARDX) -13%, Pacific Biosciences of California (PACB) -13%, ALX Oncolo...
MicroVision (MVIS) -24% on Q1 earnings release.Ardelyx (ARDX) -18% after tenapanor PDUFA extension.Twitter (TWTR) -13% on Q1 earnings release.Eros STX Global (ESGC) -11%.CPS Technologies (CPSH) -10% on Q1 earnings release.Brooklyn ImmunoTherapeutics (BT...
Gainers: Willamette Valley Vineyards (WVVI) +55%.Ocular Therapeutix (OCUL) +23%.Galera Therapeutics (GRTX) +23%.JAKKS Pacific (JAKK) +21%.ShiftPixy (PIXY) +19%.1-800-FLOWERS.COM (FLWS) +18%.MEDIROM Healthcare Technologies (MRM) +16%.VEREIT (VER) +16%.Communications Systems (JCS) +15%.Dol...
News, Short Squeeze, Breakout and More Instantly...
Brooklyn ImmunoTherapeutics Inc. Company Name:
BTX Stock Symbol:
NYSE Market:
Brooklyn ImmunoTherapeutics Inc. Website:
New name reflects Company focus on leveraging exclusively in-licensed foundational mRNA cell engineering patent portfolio The Eterna corporate mission is to realize the potential of cell engineering to provide patients with transformational new medicines Company’s...
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”) today announces results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnos...
SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, today ann...